Courtney Thorne


I take life sciences companies public and then I'm there to help clients navigate the waters of being an SEC reporting company.

Courtney T. Thorne's practice focuses on the representation of public companies and investment banks in the life sciences industry, with an emphasis on capital raising, public company counseling, foreign private issuer matters and securities law compliance. In addition to a robust US practice, she has substantial expertise advising non-US companies (known as foreign private issuers or FPIs) seeking to access the US capital markets or to list on a US securities exchange. Over the past six years, Courtney has advised 45+ IPOs and follow-on offerings, with an aggregate value of over $4.2 billion.

Download full bio 


  • CinCor Pharma – $212 Million IPO 

  • Exscientia – $510.4 Million IPO 

  • Finch Therapeutics – $128 Million IPO 

  • Immunocore – $297 Million IPO 

  • Nanobiotix – $113 Million IPO 

  • View all


    Exploring neighborhood coffee shops

    Volunteering with the Junior League of Boston



  • Suffolk University Law School
    JD, cum laude, Business Law and Financial Services Concentration, with distinction, 2010

  • George Washington University
    MPA, 2007

  • George Washington University
    BA, 2005

Admissions & Credentials


New York


  • Boston Bar Association

  • Healthcare Businesswomen's Association

Rankings & Accolades

    Massachusetts Super Lawyers: Rising Star in Business/Corporate Law and Securities & Corporate Finance
    (2015 – 2022)

    #1 Firm for European FPI US IPOs since 2016

PubCo @ Cooley Blog

Focus on providing dynamic thought leadership and curated content for the public securities arena

View blog